Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO: Prevention of Cardiovascular Events in Ischemic Stroke Patients at High Risk of Cerebral Hemorrhage
KCT0000355Phase 4Recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol, aspirin in ischemic stroke, brain hemorrhage (ICH), cerebral microbleed (CMBs), cardiac morbidity, sponsored by Korea Otsuka Pharmaceutical. Started May 2009; status: recruiting.
02
Drugs
cilostazolaspirin
03
Conditions
ischemic strokebrain hemorrhage (ICH)cerebral microbleed (CMBs)cardiac morbidity
Beyond the preview
Go deeper on KCT0000355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000355.